A reactivation of mammalian target of rapamycin 1 (mTORC1) signaling by increasing expression of solute carrier family 36 member 1 (SLC36A1), contributes Palbociclib and Ribociclib resistance in Melanoma (Yoshida et al., 2019). Here, SLC36A1 is linked to melanoma.